Pfizer’s Antiviral Covid-19 Pill Approved by U.K. Regulator
- Pfizer pill joins Merck drug in Britain’s anti-Covid armory
- Paxlovid cleared for at-risk adults with mild, moderate Covid
Source: Pfizer Inc.
This article is for subscribers only.
Britain’s regulator approved Pfizer Inc.’s Covid-19 antiviral pill as Prime Minister Boris Johnson’s government races to build an armory of weapons against the resurgent pandemic.
The Pfizer drug, Paxlovid, was authorized for use in people over 18 with mild to moderate Covid and at least one risk factor for developing severe illness, the U.K.’s Medicines and Healthcare Products Regulatory Agency said Friday.